RMTI - Rockwell Medical, Inc.
NASDAQ
->
Healthcare
->
Drug Manufacturers—Specialty & Generic
Wixom,
United States
Type: Equity
RMTI price evolution
RMTI
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $11.86 | $6.64 | $8.98 | $7.76 |
| Short term investments | $1.98 | $1.95 | $3.97 | |
| Net receivables | $10.84 | $11.09 | $10.9 | $9.36 |
| Inventory | $6.06 | $6.25 | $6.05 | $5.66 |
| Total current assets | $29.75 | $26.7 | $28.77 | $28.17 |
| Long term investments | ||||
| Property, plant & equipment | $11.14 | $11.78 | $11.02 | $11.91 |
| Goodwill & intangible assets | $11.4 | $11.54 | $11.68 | $11.82 |
| Total noncurrent assets | $23.27 | $24.03 | $23.4 | $24.43 |
| Total investments | $1.98 | $1.95 | $3.97 | |
| Total assets | $53.03 | $50.72 | $52.17 | $52.61 |
| Current liabilities | ||||
| Accounts payable | $3.35 | $4.92 | $4.52 | $3.93 |
| Deferred revenue | $0.5 | $0.51 | $0.52 | $0.53 |
| Short long term debt | $2.7 | $2.03 | $2.18 | $8.2 |
| Total current liabilities | $14.89 | $14.95 | $16.64 | $21.41 |
| Long term debt | $11.67 | $12.15 | $11.26 | $6.68 |
| Total noncurrent liabilities | $14.64 | $15.13 | $14.24 | $9.68 |
| Total debt | $14.38 | $14.18 | $13.44 | $14.88 |
| Total liabilities | $29.53 | $30.08 | $30.88 | $31.09 |
| Shareholders' equity | ||||
| Retained earnings | -$398.59 | -$398.93 | -$397.2 | -$395.69 |
| Other shareholder equity | -$0.01 | $0.02 | -$0 | $0.07 |
| Total shareholder equity | $23.5 | $20.64 | $21.29 | $21.52 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8.98 | $10.1 | $13.28 | $48.68 |
| Short term investments | $1.95 | $11.39 | $9.16 | $10 |
| Net receivables | $10.9 | $6.26 | $5.91 | $4.17 |
| Inventory | $6.05 | $7.09 | $5.6 | $5.09 |
| Total current assets | $28.77 | $35.31 | $35.29 | $69.47 |
| Long term investments | ||||
| Property, plant & equipment | $11.02 | $8.61 | $10.22 | $5.55 |
| Goodwill & intangible assets | $11.68 | $0.92 | $0.92 | $0.92 |
| Total noncurrent assets | $23.4 | $11.32 | $13.29 | $8.28 |
| Total investments | $1.95 | $11.39 | $9.16 | $10 |
| Total assets | $52.17 | $46.63 | $48.57 | $77.75 |
| Current liabilities | ||||
| Accounts payable | $4.52 | $4.05 | $3.74 | $4.16 |
| Deferred revenue | $0.52 | $4.33 | $8.16 | $10.19 |
| Short long term debt | $2.18 | $4.14 | $9.82 | $1.17 |
| Total current liabilities | $16.64 | $17.69 | $20.97 | $12.79 |
| Long term debt | $11.26 | $12.22 | $19.07 | $22.77 |
| Total noncurrent liabilities | $14.24 | $14.84 | $25.07 | $30.79 |
| Total debt | $13.44 | $16.36 | $28.89 | $23.94 |
| Total liabilities | $30.88 | $32.53 | $46.04 | $43.58 |
| Shareholders' equity | ||||
| Retained earnings | -$397.2 | -$388.76 | -$370.08 | -$337.41 |
| Other shareholder equity | -$0 | $0.16 | $0.05 | $0.06 |
| Total shareholder equity | $21.29 | $14.11 | $2.54 | $34.17 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $25.83 | $22.68 | $22.09 | $23.77 |
| Cost of revenue | $21.28 | $19.61 | $19.22 | $21.57 |
| Gross Profit | $4.55 | $3.06 | $2.87 | $2.2 |
| Operating activities | ||||
| Research & development | $0.02 | $0.17 | $0.49 | |
| Selling, general & administrative | $4.04 | $4.37 | $3.25 | $3.44 |
| Total operating expenses | $4.04 | $4.39 | $3.42 | $3.94 |
| Operating income | $0.52 | -$1.32 | -$0.55 | -$1.74 |
| Income from continuing operations | ||||
| EBIT | $0.57 | -$1.3 | -$0.4 | -$1.46 |
| Income tax expense | ||||
| Interest expense | $0.23 | $0.43 | $1.11 | $0.41 |
| Net income | ||||
| Net income | $0.34 | -$1.73 | -$1.51 | -$1.87 |
| Income (for common shares) | $0.34 | -$1.73 | -$1.51 | -$1.87 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $83.61 | $72.81 | $61.93 | $62.2 |
| Cost of revenue | $74.91 | $68.73 | $64.35 | $59.47 |
| Gross Profit | $8.7 | $4.08 | -$2.42 | $2.73 |
| Operating activities | ||||
| Research & development | $1.11 | $3.12 | $6.83 | $7.09 |
| Selling, general & administrative | $14.27 | $17.74 | $21.08 | $24.05 |
| Total operating expenses | $15.37 | $20.86 | $27.92 | $31.14 |
| Operating income | -$6.67 | -$16.78 | -$30.34 | -$28.42 |
| Income from continuing operations | ||||
| EBIT | -$6.14 | -$16.74 | -$30.31 | -$29.01 |
| Income tax expense | ||||
| Interest expense | $2.3 | $1.94 | $2.36 | $1.88 |
| Net income | ||||
| Net income | -$8.44 | -$18.68 | -$32.67 | -$30.89 |
| Income (for common shares) | -$8.44 | -$18.68 | -$32.67 | -$30.89 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $0.34 | -$1.73 | -$1.51 | -$1.87 |
| Operating activities | ||||
| Depreciation | $0.97 | $1.06 | $1.03 | $1.08 |
| Business acquisitions & disposals | -$12.36 | |||
| Stock-based compensation | $0.34 | $0.25 | $0.22 | $0.21 |
| Total cash flows from operations | $1.44 | -$2.38 | -$0.04 | -$3.75 |
| Investing activities | ||||
| Capital expenditures | -$0.29 | -$0.14 | -$0.04 | -$0.02 |
| Investments | $2 | $2.05 | $2.09 | |
| Total cash flows from investing | $1.72 | -$0.14 | $2.01 | -$10.29 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $2.2 | $0.56 | $1.1 | $13.76 |
| Net borrowings | -$0.14 | -$0.38 | -$1.88 | -$0.88 |
| Total cash flows from financing | $2.06 | $0.18 | -$0.74 | $12.85 |
| Effect of exchange rate | -$0 | $0 | -$0 | |
| Change in cash and equivalents | $5.22 | -$2.34 | $1.22 | -$1.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$8.44 | -$18.68 | -$32.67 | -$30.89 |
| Operating activities | ||||
| Depreciation | $3.45 | $2.59 | $2.52 | $2.29 |
| Business acquisitions & disposals | -$12.36 | |||
| Stock-based compensation | $0.93 | $0.32 | $0.94 | $0.47 |
| Total cash flows from operations | -$9.41 | -$17.41 | -$33.53 | -$29.64 |
| Investing activities | ||||
| Capital expenditures | -$0.28 | -$0.28 | -$0.52 | -$1.05 |
| Investments | $9.6 | -$2.12 | $0.83 | $4.26 |
| Total cash flows from investing | -$3.04 | -$2.4 | $0.31 | $3.21 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $14.86 | $29.82 | $0.1 | $42.92 |
| Net borrowings | -$3.51 | -$13.19 | -$2.28 | $20.39 |
| Total cash flows from financing | $11.34 | $16.63 | -$2.18 | $63.32 |
| Effect of exchange rate | -$0 | |||
| Change in cash and equivalents | -$1.12 | -$3.18 | -$35.4 | $36.89 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $94.37M |
|---|---|
| EBITDA | $1.55M |
| EBIT | -$2.59M |
| Net Income | -$4.77M |
| Revenue Q/Q | 42.88% |
| Revenue Y/Y | 24.58% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | -9.15% |
| ROE | -21.95% |
| Debt/Equity | 1.45 |
|---|---|
| Net debt/EBITDA | 11.38 |
| Current ratio | 2.00 |
| Quick ratio | 1.59 |